NSERecord Date29 Aug 2026 · 29 Aug 2026, 03:22 pm

Record Date

Lincoln Pharmaceuticals Limited · LINCOLN

✦ AI SummaryDividend

Lincoln Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Sep-2026.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Lincoln Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Sep-2026.

Attachments (1)

📄

LINCOLN_29082026152219_Intimation_-Intimation_of_Record_Date.pdf

pdf

Download →
View document text
LINCOLN PHARMACEUTICALS LTD. HEALTHCARE FOR ALL Date: August 29, 2026 To To The Manager, The Manager, Listing Department, The Department of Corporate Service, National Stock Exchange of India Limited, (NSE) BSE Limited, (BSE) Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra Phiroze Jeejeebhoy Tower, (E), Mumbai – 400 051. Dalal Street, Mumbai – 400 001. Scrip Code – LINCOLN Scrip Code – 531633 Dear Sir / Madam, Sub: Intimation of Book Closure and Record Date for the purpose of 32nd Annual General Meeting and Final Dividend for the Financial Year 2025-26. Pursuant to the Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the 32nd Annual General Meeting of the Company is scheduled to be held on Wednesday, September 30, 2026 at 11:00 a.m. (IST) through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM"). The details of the Book closure and Record Date as per Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are as given below: Particulars Details Type of security Equity shares of Rs. 10/- each Record Date Friday, September 11, 2026 Book Closure Start Date Saturday, September 12, 2026 Book Closure End Date Wednesday, September 30, 2026 For determining the entitlement of members for payment of Dividend if approved at Purpose the 32nd Annual General Meeting. Corporate Action Dividend/AGM Dividend (%) 18% Dividend Type Final Dividend: ₹ 1.80/- Per Equity Share of Face Value of ₹ 10/- each Dividend for the Financial Year April 01, 2025 to March 31, 2026 Meeting (AGM) Date Wednesday, September 30, 2026 The Final Dividend is payable only when the same is approved by the members at the 32nd Annual General Meeting. We hope you will find the same in order and take the same on records. Thanking you, Yours faithfully, For Lincoln Pharmaceuticals Limited Trusha Shah Company Secretary & Compliance Officer CC to: 1. National Securities Depository Limited 2. Central Depository Services (India) Limited 3. MUFG lntime India Private Limited Regd. Office: "Lincoln House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India ���� Phone: +91-79-4107 8000 I Fax: +91-79-4107 8062 I CIN L24230GJ1995PLC024288 E-mail: info@lincolnpharma.com I Website : www.lincolnpharma.com Factory: 10, 12, 13, Trimul Estate, Near Khatraj Chokadi, P.O. Khatraj-382721. lntertek 014 Ta.: Kalol, Dist. Gandhinagar, [Guj.] I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com